TY  - JOUR 
AU  - Vicente Vicente, Rosa Laura
AU  - Sánchez Juanes, Fernando
AU  - García Sánchez, Omar
AU  - Blanco Gozalo, Víctor
AU  - Pescador Garriel, Moisés
AU  - Sevilla Toral, María Ángeles
AU  - González de Buitrago Arriero, José Manuel
AU  - López Hernández, Francisco José
AU  - López-Novoa, José M.
AU  - Morales Martín, Ana Isabel
PY  - 2015
SN  - 0378-4274
UR  - http://hdl.handle.net/10366/154705
AB  - [EN]Nephrotoxicity limits the therapeutic efficacy of the antineoplastic drug cisplatin. Due to dosage adjustment and appropriate monitoring, most therapeutic courses with cisplatin produce no or minimal kidney damage. However, we studied whether even...
LA  - eng
PB  - Elsevier
KW  - Acute kidney injury
KW  - Acquired predisposition
KW  - Cisplatin
KW  - Urinary biomarkers
KW  - Fumarylacetoacetase
KW  - Cisplatin
KW  - Gentamicins
KW  - Risk Assessment
KW  - Humans
KW  - Hydrolases
KW  - Kidney
KW  - Antineoplastic Agents
KW  - Time Factors
KW  - Acute Kidney Injury
KW  - Rats
KW  - Risk Factors
KW  - Animals
KW  - Up-Regulation
TI  - Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase
DO  - 10.1016/j.toxlet.2014.11.033
T2  - Toxicology Letters
VL  - 234
M2  - 99
ER  -